Clinical Trial Update: Effects of Semaglutide in HIV-Associated Lipohypertrophy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating semaglutide for HIV-associated lipohypertrophy has posted results (trial status ACTIVE_NOT_RECRUITING; results posted in 2026).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids
• Lipohypertrophy
• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Case Western Reserve University | Conditions: HIV/AIDS, Lipohypertrophy | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-17